Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Effects of Synvisc on Cartilage in Knee Osteoarthritis (OA) (NCT00949494)Endeavor Health2006-09-01
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis (NCT00361634)Amgen2006-09-01
Telephone Counseling: Men With Prostate Cancer & Partners (NCT00822510)University of Arizona2006-09-01
Asthma and Mindfulness-Based Stress Reduction (MBSR) (NCT00682669)University of Massachusetts, Worcester2006-09-01
Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant (NCT00388999)Enzon Pharmaceuticals, Inc.2006-09-01
Joint Attention Intervention and Young Children With Autism (NCT00378157)Ullevaal University Hospital2006-09-01
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis (NCT00412464)Children's Hospital Los Angeles2006-09-01
A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD) (NCT00347646)Bausch & Lomb Incorporated2006-09-01
A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT02507375)Hoffmann-La Roche2006-09-01
Study Evaluating PSI-697 in Patients With Scleritis (NCT00367692)Wyeth is now a wholly owned subsidiary of Pfizer2006-09-01
Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI) (NCT00371371)UMC Utrecht2006-09-01
Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed Conditions (NCT01267383)Dr. Reddy's Laboratories Limited2006-09-01
Acupuncture for the Treatment of Phantom Limb and Residual Limb Pain After Amputation (NCT00388752)Walter Reed Army Medical Center2006-09-01
A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group (NCT00986895)Amgen2006-09-01
Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients (NCT00402116)Eli Lilly and Company2006-09-01
Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial (NCT00378196)Johns Hopkins University2006-09-01
A Phase I/II Study of MGCD0103 (MG-0103) in Combination With Gemcitabine (NCT00372437)Mirati Therapeutics Inc.2006-09-01
Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid (NCT00381433)Sarepta Therapeutics, Inc.2006-09-01
Scintigraphic Assessment Following Klean-Prep® or Moviprep® (NCT00896246)Norgine2006-09-01
Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk (NCT00507715)Rottapharm Spain2006-09-01
Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy (NCT00401115)Santen Inc.2006-09-01
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers (NCT02194309)Boehringer Ingelheim2006-09-01
Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias (NCT00522990)Astex Pharmaceuticals, Inc.2006-09-01
Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects (NCT00480818)Wyeth is now a wholly owned subsidiary of Pfizer2006-09-01
Safety, Tolerability and Pharmacokinetics of BEA 2180 BR in Healthy Male Volunteers (NCT02254720)Boehringer Ingelheim2006-09-01
Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00377104)National Cancer Institute (NCI)2006-09-01
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers (NCT00284908)STEBA France2006-09-01
Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer (NCT00423397)University of California, San Diego2006-09-01
Study to Determine the Impact of Multiple Doses of Rifampin on Single-dose Pharmacokinetics of HCV-796 (NCT00384280)Wyeth is now a wholly owned subsidiary of Pfizer2006-09-01
S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00352443)SWOG Cancer Research Network2006-09-01
Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects (NCT02182323)Boehringer Ingelheim2006-09-01
Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM (NCT00370006)University of California, San Francisco2006-09-01
Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol (NCT00422552)Novartis2006-09-01
Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma (NCT00356460)Genzyme, a Sanofi Company2006-09-01
Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma (NCT01233895)Sanofi2006-09-01
Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma (NCT00383097)Baylor College of Medicine2006-09-01
Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone (NCT00376324)Wyeth is now a wholly owned subsidiary of Pfizer2006-09-01
Modified Vaccinia Ankara (MVA) Vaccine Study (NCT01256853)Chinese University of Hong Kong2006-09-01
Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome (NCT00438321)Massachusetts General Hospital2006-09-01
Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma (NCT00363090)Toronto Sunnybrook Regional Cancer Centre2006-09-01
Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder (NCT00380042)Northstar Neuroscience2006-09-01
RTA 744 Injection in Patients With Leptomeningeal Disease (NCT00512460)M.D. Anderson Cancer Center2006-09-01
Dose-Finding Study of WS6788A and LSN03-016011/A Enterotoxigenic E. Coli ETEC Challenge Strains That Express CS17 (NCT00564577)Johns Hopkins Bloomberg School of Public Health2006-09-01
A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults (NCT00385047)U.S. Army Medical Research and Development Command2006-09-01
Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients (NCT02172534)Boehringer Ingelheim2006-09-01
Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples (NCT00629577)British Columbia Cancer Agency2006-09-01
Extrapleural Intercostal Catheter vs. Thoracic Epidural for Thoracotomy Pain (NCT00373633)Virginia Commonwealth University2006-09-01
High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy (NCT00604526)Memorial Sloan Kettering Cancer Center2006-09-01
Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors (NCT00364143)Yakult Honsha Co., LTD2006-09-01
Abuse-Focused Cognitive Behavioral Therapy for Children Who Have Been Physically Abused (NCT00494286)University of Pittsburgh2006-09-01
Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors (NCT00395434)Mateon Therapeutics2006-09-01
Rapamycin With Grapefruit Juice for Advanced Malignancies (NCT00375245)University of Chicago2006-09-01
FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects (NCT00370097)GlaxoSmithKline2006-08-30
Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma (NCT00406757)GlaxoSmithKline2006-08-30
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome (NCT00369629)Northwestern University2006-08-28
Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food (NCT00419692)GlaxoSmithKline2006-08-24
Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT00483366)University of Nebraska2006-08-15
Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia (NCT00366418)National Heart, Lung, and Blood Institute (NHLBI)2006-08-10
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors (NCT00743067)GlaxoSmithKline2006-08-09
A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002) (NCT00635778)Merck Sharp & Dohme LLC2006-08-07
Benefits of 'Repeat Back' Protocols Within A Computer-Based Informed Consent Program (NCT00288899)VA Office of Research and Development2006-08-07
Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) (NCT00440726)Therapeutic Advances in Childhood Leukemia Consortium2006-08-04
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients (NCT00369798)National Institute of Mental Health (NIMH)2006-08-02
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis (NCT00639808)Tranzyme, Inc.2006-08-01
Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Under Fasting Conditions (NCT01132170)Dr. Reddy's Laboratories Limited2006-08-01
Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions (NCT00759902)Actavis Inc.2006-08-01
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase (NCT00324077)Bristol-Myers Squibb2006-08-01
Study Evaluating LXR-623 in Healthy Subjects (NCT00366522)Wyeth is now a wholly owned subsidiary of Pfizer2006-08-01
Bioavailability of Insulin Administered in Duodenum (NCT00353990)University of Aarhus2006-08-01
Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies. (NCT00426140)Novartis Pharmaceuticals2006-08-01
Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer (NCT00403221)Baylor College of Medicine2006-08-01
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma (NCT00509431)Jonsson Comprehensive Cancer Center2006-08-01
Study to Determine Effective Dosing of Fondaparinux in Obese Persons (NCT00346879)Indiana University2006-08-01
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors (NCT00307255)UNC Lineberger Comprehensive Cancer Center2006-08-01
Randomized Controlled Trial of Hyperbaric Oxygen in Patients Who Have Taken Bisphosphonates (NCT00462098)Duke University2006-08-01
Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV (NCT02229760)Boehringer Ingelheim2006-08-01
Use of Modafinil in the Treatment of Tinnitus (NCT00591019)University of Arkansas2006-08-01
Neural Control of Non-invasive Ventilation in the Preterm (NCT00368485)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2006-08-01
A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine (NCT00419783)Faes Farma, S.A.2006-08-01
Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy (NCT00372983)Cellectar Biosciences, Inc.2006-08-01
CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NCT00374179)Adnexus, A Bristol-Myers Squibb R&D Company2006-08-01
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Powder in Healthy Male Subjects (NCT02209844)Boehringer Ingelheim2006-08-01
Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy (NCT00403325)Vitreous -Retina- Macula Consultants of New York2006-08-01
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin (NCT00423852)Memorial Sloan Kettering Cancer Center2006-08-01
Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides (NCT00365937)Cliniques universitaires Saint-Luc- Université Catholique de Louvain2006-08-01
Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer (NCT00311623)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2006-08-01
Rituximab Treatment in Sjogren's Syndrome (NCT00363350)University Medical Center Groningen2006-08-01
Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD) (NCT00687245)AstraZeneca2006-08-01
131-I-TM-601 Study in Adults With Solid Tumors (NCT00379132)TransMolecular2006-08-01
Atrial Fibrillation Ablation Pilot Study (NCT00744835)Medtronic Cardiac Rhythm and Heart Failure2006-08-01
A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy (NCT00465569)Johns Hopkins University2006-08-01
Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer (NCT00387465)National Cancer Institute (NCI)2006-08-01
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release (NCT00367302)National Development and Research Institutes, Inc.2006-08-01
Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors (NCT00426582)Novartis Pharmaceuticals2006-08-01
AS703569 Phase I in Patients With Solid Tumours (NCT00391521)EMD Serono2006-08-01
A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment (NCT01183598)Hoffmann-La Roche2006-08-01
Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase (NCT00383474)National Cancer Institute (NCI)2006-08-01
Prediction Frozen Shoulder Validation (NCT01157221)National Taiwan University Hospital2006-08-01
Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer (NCT00496509)Genzyme, a Sanofi Company2006-08-01
Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) (NCT00871663)Merck Sharp & Dohme LLC2006-08-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.